A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber

Clinical trial NCT02481856 · COMPLETED

Trial details

NCT number: NCT02481856
Sponsor: ALK-Abelló A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinoconjunctivitis

Start date: 2015-06-01
Primary completion: 2016-04-01
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.